[go: up one dir, main page]

PT91153A - Processo para a preparacao de um ester de 9-(2-hidroxi-etoxi-metil)guanina e de composicoes que contem - Google Patents

Processo para a preparacao de um ester de 9-(2-hidroxi-etoxi-metil)guanina e de composicoes que contem

Info

Publication number
PT91153A
PT91153A PT91153A PT9115389A PT91153A PT 91153 A PT91153 A PT 91153A PT 91153 A PT91153 A PT 91153A PT 9115389 A PT9115389 A PT 9115389A PT 91153 A PT91153 A PT 91153A
Authority
PT
Portugal
Prior art keywords
preparation
ester
guanin
ethoxy
hydroxy
Prior art date
Application number
PT91153A
Other languages
English (en)
Other versions
PT91153B (pt
Inventor
Lilia Marie Beauchamp
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PT91153A publication Critical patent/PT91153A/pt
Publication of PT91153B publication Critical patent/PT91153B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
PT91153A 1988-07-14 1989-07-13 Processo para a preparacao de um ester de 9-(2-hidroxi-etoxi-metil)guanina e de composicoes que contem PT91153B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888816760A GB8816760D0 (en) 1988-07-14 1988-07-14 Therapeutic compounds

Publications (2)

Publication Number Publication Date
PT91153A true PT91153A (pt) 1990-02-08
PT91153B PT91153B (pt) 1995-01-31

Family

ID=10640438

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91153A PT91153B (pt) 1988-07-14 1989-07-13 Processo para a preparacao de um ester de 9-(2-hidroxi-etoxi-metil)guanina e de composicoes que contem

Country Status (19)

Country Link
US (1) US5079252A (pt)
EP (1) EP0351215B1 (pt)
JP (1) JP2791116B2 (pt)
KR (1) KR900001697A (pt)
AT (1) ATE139535T1 (pt)
AU (1) AU622686B2 (pt)
CA (1) CA1331611C (pt)
DE (1) DE68926697T2 (pt)
DK (1) DK347289A (pt)
FI (1) FI91155C (pt)
GB (1) GB8816760D0 (pt)
HU (1) HU210425B (pt)
IE (1) IE892261L (pt)
IL (1) IL90959A (pt)
MY (1) MY104124A (pt)
NZ (1) NZ229929A (pt)
PH (1) PH26913A (pt)
PT (1) PT91153B (pt)
ZA (1) ZA895345B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162459A (en) * 1995-02-24 2000-12-19 National Science Council Acyclovir transdermal delivery system
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
US5677308A (en) * 1996-12-19 1997-10-14 Lerner; A. Martin Method for alleviating spasmodic torticollis
US5872123A (en) * 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6107303A (en) * 1999-03-15 2000-08-22 Demarco; Charlene C. Treatment of Epstein Barr infection
US20030212051A1 (en) * 2001-04-06 2003-11-13 Polli James E Bile acid containing prodrugs with enhanced bioavailabilty
WO2013011336A2 (en) 2011-07-15 2013-01-24 Budapesti Műszaki és Gazdaságtudományi Egyetem Data input device
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561380A (en) * 1976-03-01 1980-02-20 Wellcome Found Esters of hydroxyalkoxyalkyl purines their preparation and pharmaceutical compositions containing them
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
AU515553B2 (en) * 1976-03-01 1981-04-09 The Wellcome Foundation Limited Purine derivatives
US4287188A (en) * 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4745119A (en) * 1982-10-14 1988-05-17 Burroughs Wellcome Co. Method for using purine derivatives
US4695570A (en) * 1982-10-14 1987-09-22 Burroughs Wellcome Co. Antiviral compound use
US4544634A (en) * 1982-10-14 1985-10-01 Burroughs Wellcome Co. Method of producing acyclovir
US4612314A (en) * 1982-12-22 1986-09-16 Syntex (U.S.A.) Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
IL74881A0 (en) * 1984-04-13 1985-07-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
EP0564006A3 (en) * 1987-05-04 1993-12-15 Krka Tovarna Zdravil Process for preparing purine derivatives and novel purine derivatives
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.

Also Published As

Publication number Publication date
AU3809789A (en) 1990-01-18
JPH0273086A (ja) 1990-03-13
EP0351215A3 (en) 1991-08-14
ATE139535T1 (de) 1996-07-15
GB8816760D0 (en) 1988-08-17
US5079252A (en) 1992-01-07
AU622686B2 (en) 1992-04-16
DK347289D0 (da) 1989-07-13
NZ229929A (en) 1992-02-25
EP0351215A2 (en) 1990-01-17
PH26913A (en) 1992-12-03
PT91153B (pt) 1995-01-31
JP2791116B2 (ja) 1998-08-27
EP0351215B1 (en) 1996-06-19
ZA895345B (en) 1991-03-27
DE68926697T2 (de) 1996-12-12
FI893408A0 (fi) 1989-07-13
MY104124A (en) 1993-12-31
IL90959A0 (en) 1990-02-09
FI91155C (fi) 1994-05-25
KR900001697A (ko) 1990-02-27
CA1331611C (en) 1994-08-23
FI91155B (fi) 1994-02-15
IE892261L (en) 1990-01-14
HU210425B (en) 1995-04-28
FI893408A (fi) 1990-01-15
IL90959A (en) 1994-02-27
DK347289A (da) 1990-01-15
HUT50821A (en) 1990-03-28
DE68926697D1 (de) 1996-07-25

Similar Documents

Publication Publication Date Title
PT82580B (pt) Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
NO2007016I2 (no) Nelarabin eller et farmasoytisk akseptabelt salt derav ( nelarabin=9-(beta-D-arabinofuranosyl-2-amino-6-metoksy-9H-purin)
ATE123285T1 (de) Antivirale pyrimidin- und purinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate.
MX173630B (es) Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene
ES2147294T3 (es) Compuestos terapeuticos.
PT91153A (pt) Processo para a preparacao de um ester de 9-(2-hidroxi-etoxi-metil)guanina e de composicoes que contem
DE3875769D1 (de) Therapeutische nukleoside.
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
DK0484112T3 (da) Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum
UY23844A1 (es) Agentes antivirosicos.
MX9307479A (es) Uso de ciertos derivados de acido metanobisfosfonico en la curacion de fracturas.
ES2136061T3 (es) Nucleosidos terapeuticos.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940721

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970131